Sjs Investment Consulting Inc. Acadia Pharmaceuticals Inc Transaction History
Sjs Investment Consulting Inc.
- $567 Million
- Q2 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 9 shares of ACAD stock, worth $211. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9Holding current value
$211% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
351Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$1.01 Billion8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$358 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$284 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$201 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$165 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.81B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...